Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

gemcitabine

Gemzar, gemcitabine, is a chemotherapy drug for infusion.

Therapeutic indications are:

  1. Non Small Cell Lung Cancer: Gemcitabine is indicated for the palliative treatment of patients with locally advanced
    or metastatic non-small cell lung cancer.
  2. Breast cancer: Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant / neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.
  3. Pancreatic Cancer: Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer.
  4. Bladder Cancer: Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage.

 

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life are our main business. We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics

Close Menu